Page last updated: 2024-08-23

penfluridol and Colorectal Neoplasms

penfluridol has been researched along with Colorectal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dai, PF; Li, H; Li, L; Lv, XF; Ren, F; Wang, HN; Wang, NN; Zhang, J; Zhang, PZ	1

Other Studies

1 other study(ies) available for penfluridol and Colorectal Neoplasms

Article	Year
Penfluridol triggers mitochondrial-mediated apoptosis and suppresses glycolysis in colorectal cancer cells through down-regulating hexokinase-2. Anatomical record (Hoboken, N.J. : 2007), 2021, Volume: 304, Issue:3 Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Down-Regulation; Glycolysis; Hexokinase; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Penfluridol; Xenograft Model Antitumor Assays	2021

Article

Year

Penfluridol triggers mitochondrial-mediated apoptosis and suppresses glycolysis in colorectal cancer cells through down-regulating hexokinase-2.

Anatomical record (Hoboken, N.J. : 2007), 2021, Volume: 304, Issue:3

Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Down-Regulation; Glycolysis; Hexokinase; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Penfluridol; Xenograft Model Antitumor Assays

2021